November 30, 2015

November 30, 2015

Episodes

Specialty:

All

Year:

All

EP. 1: Conference Highlights, Three FDA Approvals, and More

November 30th 2015

EP. 2: UC Davis Meets NCI-Designation With Great Responsibility

November 30th 2015

Trending on OncLive

FDA Approves Iberdomide Plus Daratumumab/Dexamethasone for R/R Myeloma

Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma

Frequently Asked Questions on the Evolving Management of Early-Stage HER2+ Breast Cancer

Study Finds Traditional Prostate Cancer Risk Factors Do Not Predict Hormone Therapy Benefit

Dr Garg on a Phase 3 Study of Proton Therapy in Head and Neck Cancer